Having qualified as a doctor from Barts and the Royal London in 1997, Miss Deol was the first woman to enter the Royal London Hospital general surgical rotation in over 20 years. Further senior specialist general surgical training was in the highly regarded North-East Thames rotation in London, where she also undertook a paediatric surgery fellowship at the Royal London Children’s Hospital.
Specialing in breast surgery, she gained extensive training in numerous London breast units and the Royal Marsden Hospital (Sutton), prior to being awarded a prestigious British Association of Surgical Oncology Oncoplastic Breast Surgery National Fellowship.
In addition, Miss Deol has presented her research work at national and international medical conferences, as well as being a contributing author of a chapter in a surgical oncology textbook.
Miss Deol is an active trainer and examiner for junior surgeons and medical students, specialising in the teaching of clear communication to patients, women’s health, breast surgery and general surgery. (University of Cambridge, University College Hospital London, Barts and The Royal London Hospital Medical Schools and London Deanery Senior Surgical Trainees.
Miss Deol’s approach is to provide clear and concise information and explanations to her patients, up-to-date and evidence-based treatment, focusing on the medical management of breast cancer, psychological support for patients through their treatment and a range of innovative surgical methods appropriately.
As a consultant breast surgeon, she incorporates the latest plastic surgery techniques in the management of breast cancer (oncoplastic breast surgery), allowing for an improved cosmetic outcome and breast appearance after surgery. These have the proven benefit of better psychological recovery from the impact of breast surgery.
Miss Deol treats breast problems of any nature, benign or cancerous and patients with a family history of breast cancer. She performs immediate and delayed breast reconstructions and symmetrisation surgery (breast reduction or augmentation) in patients with breast cancer.